Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Medical Device Network sits down with David Leslie of the Alan Turing Institute to understand what, if any, rules AI should ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...

China's agriculture ministry issued guidelines on Friday to promote biotech cultivation from 2024 to 2028, a ministry statement showed. The focus will be on developing precision ...

China issued guidelines on Friday to promote biotech cultivation, focusing on gene-editing tools and developing new wheat, ...

Investment analysts at HC Wainwright dropped their Q2 2025 earnings estimates for Enanta Pharmaceuticals in a report released on Tuesday, February 11th. HC Wainwright analyst E. Arce now expects that ...

Prime Minister Narendra Modi held a meeting with Indian-origin entrepreneur and Republican leader Vivek Ramaswamy and his ...

The justices’ precedents imply that he has the power to dismiss officials of ‘independent’ agencies.

Research has uncovered key differences in gene expression linked to inflammation, metabolism and cardioprotection. These findings could help inform the development of targeted therapies for ...

By engaging with AI development through thoughtful content curation and sophisticated rights management, the industry can ...